Monte Rosa Therapeutics Inc (GLUE)
8.48
-0.15
(-1.74%)
USD |
NASDAQ |
Nov 14, 16:00
8.48
0.00 (0.00%)
After-Hours: 20:00
Monte Rosa Therapeutics Price to Book Value: 2.316 for Nov. 14, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 14, 2024 | 2.316 |
| November 13, 2024 | 2.357 |
| November 12, 2024 | 2.494 |
| November 11, 2024 | 2.734 |
| November 08, 2024 | 2.530 |
| November 07, 2024 | 2.603 |
| November 06, 2024 | 2.581 |
| November 05, 2024 | 2.557 |
| November 04, 2024 | 2.415 |
| November 01, 2024 | 2.431 |
| October 31, 2024 | 2.322 |
| October 30, 2024 | 2.519 |
| October 29, 2024 | 2.560 |
| October 28, 2024 | 2.590 |
| October 25, 2024 | 1.336 |
| October 24, 2024 | 1.330 |
| October 23, 2024 | 1.330 |
| October 22, 2024 | 1.450 |
| October 21, 2024 | 1.489 |
| October 18, 2024 | 1.508 |
| October 17, 2024 | 1.500 |
| October 16, 2024 | 1.502 |
| October 15, 2024 | 1.399 |
| October 14, 2024 | 1.344 |
| October 11, 2024 | 1.347 |
| Date | Value |
|---|---|
| October 10, 2024 | 1.322 |
| October 09, 2024 | 1.311 |
| October 08, 2024 | 1.366 |
| October 07, 2024 | 1.385 |
| October 04, 2024 | 1.390 |
| October 03, 2024 | 1.396 |
| October 02, 2024 | 1.472 |
| October 01, 2024 | 1.448 |
| September 30, 2024 | 1.448 |
| September 27, 2024 | 1.412 |
| September 26, 2024 | 1.464 |
| September 25, 2024 | 1.505 |
| September 24, 2024 | 1.554 |
| September 23, 2024 | 1.625 |
| September 20, 2024 | 1.770 |
| September 19, 2024 | 1.707 |
| September 18, 2024 | 1.625 |
| September 17, 2024 | 1.617 |
| September 16, 2024 | 1.535 |
| September 13, 2024 | 1.661 |
| September 12, 2024 | 1.628 |
| September 11, 2024 | 1.699 |
| September 10, 2024 | 1.737 |
| September 09, 2024 | 1.620 |
| September 06, 2024 | 1.554 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.6783
Minimum
Oct 25 2023
5.489
Maximum
Sep 03 2021
1.735
Average
1.523
Median
Dec 16 2022
Price to Book Value Benchmarks
| Novartis AG | 4.772 |
| MEI Pharma Inc | 0.6074 |
| Evoke Pharma Inc | 1.479 |
| Revance Therapeutics Inc | -- |
| Vera Therapeutics Inc | 10.73 |
Price to Book Value Related Metrics
| Price | 8.48 |
| Earnings Yield | -26.42% |
| Market Cap | 520.44M |